Progyny, Inc. Accumulated Other Comprehensive Income
Progyny, Inc. (PGNY) had Accumulated Other Comprehensive Income of $245.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-07
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $245.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $277.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $498.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $419.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $245.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $277.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $498.00K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $419.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $218.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $110.00K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $39.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $330.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.02M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $2.75M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $2.82M 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.85M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.08M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $724.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $501.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $205.00K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $18.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | -$11.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | -$93.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | -$312.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | -$270.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$50.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $1.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $17.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $5.00K 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |